Should we use platelet‐rich plasma as an adjunct therapy to treat “acute wounds,” “burns,” and “laser therapies”: A review and a proposal of a quality criteria checklist for further studies

Platelet‐rich plasma seems to help wound healing. The goal of this review is to determine if the adjunction of platelet‐rich plasma enhances the clinical outcome of acute wounds, burns, and laser therapies. A PubMed and Cochrane library search was performed by two reviewers with the senior author as a consultant. Medical Subject Headings search terms used were the following: “Platelet‐rich plasma” OR “Platelet gel” OR “Platelet growth factor”] AND “Acute wound” OR “Wound” OR “Burn” OR “Laser”]. We included controlled studies assessing the clinical outcome of acute wounds, burns, and laser therapies treated by platelet‐rich plasma. Nine randomized controlled studies, six prospective controlled studies, and two retrospective controlled studies were included. Regarding acute wounds, three randomized controlled trials found a statistical benefit regarding either the healing time, the return back to work time, the quality of life, or the pain and three prospective controlled studies found a statistical difference regarding the velocity of healing. Platelet‐rich plasma decreased the intensity or duration of erythema after laser therapy in four randomized studies. Regarding the long‐term outcome of laser therapies, two studies found a statistical benefit and two others did not. Platelet‐rich plasma accelerates acute wound healing and decreases erythema after laser therapies. Its use on burns has not been enough studied.